Providing Global Access to Essential Medicines for Children – The WHO Better Medicines for Children Programme

Author(s):  
Kalle Hoppu ◽  
Suzanne Hill
Author(s):  
Órla O’Donovan

The profound inadequacies of Western modernist ways of thinking have been revealed by the intimately connected catastrophes of climate destruction, and more recently, the coronavirus crisis. The pandemic has forced us to notice deepening inequalities and has generated troubling questions about its causes, and who and what can be sacrificed in a pandemic. The analysis offered in Evelyn de Leeuw’s essay "The rise of the consucrat" suggests that the particular type of patient advocates she calls consucrats are unlikely to engage in thinking together about these urgent questions. If anything, due to their narrow biomedical focus and alliances with the pharmaceutical industry, they are likely to facilitate catastrophe capitalism. However, within the field of patient advocacy, there is a diversity of ways of thinking, occasionally leading to bitter contention. A number of terms is needed to reflect this diversity. One group of patient advocates who have come to the fore in recent times might be called medical cosmopolitans, or cosmedics, those who are challenging opportunistic catastrophe capitalism during the pandemic and advocating for global access to essential medicines. Forcing us to notice our deep interdependencies and entanglements, the pandemic has revealed how ludicrous it is to think about patients as consumers, and the need to think about and imagine more-than-human patient advocacy.


2015 ◽  
Vol 100 (Suppl 1) ◽  
pp. S38-S42 ◽  
Author(s):  
Kalle Hoppu ◽  
Shalini Sri Ranganathan

Millions of children die every year before they reach the age of 5 years, of conditions largely treatable with existing medicines. The WHO Model List of Essential Medicines was launched in 1977 to make the most necessary drugs available to populations whose basic health needs could not be met by the existing supply system. During the first 30 years of the Model List of Essential Medicines, children's needs were not systematically considered. After adoption of the ‘Better medicines for children’ resolution by the World Health Assembly, things changed. The first WHO Model List of Essential Medicines for Children was drawn up by a Paediatric Expert Subcommittee and adopted in October 2007. The most recent, 4th Model List of Essential Medicines for Children was adopted in 2013. Data from country surveys show that access to essential medicines for children is still generally poor; much more work is needed.


The Lancet ◽  
2006 ◽  
Vol 368 (9545) ◽  
pp. 1419
Author(s):  
Hans V Hogerzeil ◽  
Suzanne Hill ◽  
Lembit Rago

2017 ◽  
Vol 18 (1) ◽  
pp. 20-22 ◽  
Author(s):  
Avram Denburg ◽  
Brijesh Arora ◽  
Ramandeep Singh Arora ◽  
Carmen Auste ◽  
Poonam Bagai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document